A new synthetic approach for preparation of efavirenz
Efavirenz, a drug that is still inaccessible to millions of people worldwide, is potent non nucleoside reverse transcriptase inhibitor (NNRTI), is one of the preferred agents used in combination therapy for first-line treatment of the human immunodeficiency virus (HIV). NNRTIs attach to and block an...
Main Author: | Chada, Sravanthi |
---|---|
Format: | Others |
Language: | English |
Published: |
Nelson Mandela Metropolitan University
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10948/15512 |
Similar Items
-
Design, synthesis and evaluation of novel inhibitors of cysteine proteases, metalloproteases and the proteasome, a unique high molecular weight proteolytic enzyme
by: Dotse, Anthony Kwabla
Published: (2009) -
Mechanisms and quantitative prediction of Efavirenz metabolism, pharmacogenetics and drug interactions
by: Xu, Cong
Published: (2014) -
Design, development and evaluation of novel lead compounds as HIV-1 enzyme inhibitors
by: Sekgota, Khethobole Cassius
Published: (2015) -
Synthesis of 6-guanidinobenzoxazinones as potential inhibitors of trypsin-like enzymes
by: Silveira, Alvito J.
Published: (2009) -
Synthesis of alpha-amino aldehydes as kallikrein inhibitors; synthetic methods for preparation of beta-substituted cysteine analogues.
by: Stanfield, Charles Freeman.
Published: (1989)